Ryosuke Tateishi

23.7k total citations · 5 hit papers
295 papers, 12.0k citations indexed

About

Ryosuke Tateishi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ryosuke Tateishi has authored 295 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Hepatology, 141 papers in Epidemiology and 59 papers in Surgery. Recurrent topics in Ryosuke Tateishi's work include Hepatocellular Carcinoma Treatment and Prognosis (133 papers), Liver Disease Diagnosis and Treatment (124 papers) and Liver Disease and Transplantation (43 papers). Ryosuke Tateishi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (133 papers), Liver Disease Diagnosis and Treatment (124 papers) and Liver Disease and Transplantation (43 papers). Ryosuke Tateishi collaborates with scholars based in Japan, United States and United Kingdom. Ryosuke Tateishi's co-authors include Shuichiro Shiina, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike, Takuma Teratani, Takao Kawabe, Shuntaro Obi, Yuji Kondo, Shinpei Sato and Ryota Masuzaki and has published in prestigious journals such as Cell, Nature Genetics and The Journal of Experimental Medicine.

In The Last Decade

Ryosuke Tateishi

280 papers receiving 11.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma

2005 656 citations Shuichiro Shiina, Shuntaro Obi et al. profile →
Percutaneous radiofrequency ablation for hepatocellular carcinoma

2005 630 citations Ryosuke Tateishi, Shuichiro Shiina et al. profile →
Relationships between percent vegetation cover and vegetation indices

1998 554 citations Ryosuke Tateishi et al. profile →
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors

2011 547 citations Shuichiro Shiina, Ryosuke Tateishi et al. The American Journal of Gastroenterology profile →
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma

2015 544 citations Naoto Fujiwara, Hayato Nakagawa et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Ryosuke Tateishi

Since Specialization

Citations

This map shows the geographic impact of Ryosuke Tateishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Tateishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Tateishi more than expected).

Fields of papers citing papers by Ryosuke Tateishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Tateishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Tateishi. The network helps show where Ryosuke Tateishi may publish in the future.

Co-authorship network of co-authors of Ryosuke Tateishi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Tateishi. A scholar is included among the top collaborators of Ryosuke Tateishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Tateishi. Ryosuke Tateishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cachexia is an independent predictor of mortality in patients with cirrhosis 2025 ·Hepatology Research ·Takao Miwa, Goki Suda, Ryosuke Tateishi, Tatsunori Hanai, Masatsugu Ohara, Yasuhiro Hagiwara, (unknown), Kazuya Okushin, Mina Nakagawa, Naoya Sakamoto, Masahito Shimizu	0
2	Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial) 2025 ·Journal of Clinical Oncology ·Yoshikuni Kawaguchi, Kiyoshi Hasegawa, Kosuke Kashiwabara, Yukiyasu Okamura, Masayuki Kurosaki, Masatoshi Kudo, Mitsuo Shimada, Naoki Yamanaka, Masafumi Inomata, Taro Yamashita, Ryosuke Tateishi, Shuichiro Shiina, Mitsuhiro Fujishiro, Yutaka Matsuyama, Masao Omata, Norihiro Kokudo	2
3	A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE) 2025 ·Liver Cancer ·Yoshinari Asaoka, Ryosuke Tateishi, Yasuhide Yamada, Takashi Kokudo, Akiko Saito, Kiyoshi Hasegawa, Hiroko Iijima, Naoya Kato, Mitsuo Shimada, Etsuro Hatano, Takumi Fukumoto, Takamichi Murakami, Hirohisa Yano, Kengo Yoshimitsu, Masayuki Kurosaki, Michiie Sakamoto, Yutaka Matsuyama, Masatoshi Kudo, Hiroaki Miyata, Norihiro Kokudo	0
4	Pre‐Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication 2025 ·Hepatology Research ·T. Nakatsuka, Ryo Nakagomi, (unknown), (unknown), Tomoharu Yamada, Kazuya Okushin, Tatsuya Minami, Masaya Sato, Koji Uchino, Yotaro Kudo, Mitsuhiro Fujishiro, Kazuhiko Koike, Ryosuke Tateishi	1
5	Report of the 23rd nationwide follow‐up survey of primary liver cancer in Japan (2014–2015) 2023 ·Hepatology Research ·Hiroko Iijima, Masatoshi Kudo, Shoji Kubo, Masayuki Kurosaki, Michiie Sakamoto, Shuichiro Shiina, Ryosuke Tateishi, (unknown), Takumi Fukumoto, Yutaka Matsuyama, Takamichi Murakami, Arata Takahashi, Hiroaki Miyata, Norihiro Kokudo	16
6	Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 2023 ·Hepatology ·Andrea Dalbeni, Rosa Lombardi, (unknown), (unknown), Grazia Pennisi, Salvatore Petta, Ryosuke Tateishi, (unknown), Antonio Colecchia, David Sacerdoti, Alessandro Mantovani, Federico Ravaioli	17
7	Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting 2022 ·Korean Journal of Radiology ·Cher Heng Tan, (unknown), (unknown), Ke Ma, Ruofan Sheng, Ying‐Hong Shi, Zhongguo Zhou, Akira Yamada, Ryosuke Tateishi	6
8	Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals 2022 ·Hepatology Communications ·Tsuyoshi Fukumoto, Tatsuya Minami, Makoto Moriyama, Tomoharu Yamada, (unknown), (unknown), Naoto Fujiwara, Ryo Nakagomi, T. Nakatsuka, Masaya Sato, Kenichiro Enooku, Hayato Nakagawa, Mitsuhiro Fujishiro, Shuichiro Shiina, Kazuhiko Koike, Ryosuke Tateishi	4
9	Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version) 2022 ·Hepatology Research ·Masatoshi Kudo, Masafumi Ikeda, Kazuomi Ueshima, Michiie Sakamoto, Shuichiro Shiina, Ryosuke Tateishi, Kazuhiro Nouso, Kiyoshi Hasegawa, Junji Furuse, Shiro Miyayama, Takamichi Murakami, Tatsuya Yamashita, Norihiro Kokudo	12
10	Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells 2021 ·Nature Immunology ·Sho Hangai, Takeshi Kawamura, Yoshitaka Kimura, (unknown), Sana Hibino, Daisuke Yamamoto, Yousuke Nakai, Ryosuke Tateishi, Masanobu Oshima, Hiroko Oshima, Tatsuhiko Kodama, Kyoji Moriya, Kazuhiko Koike, Hideyuki Yanai, Tadatsugu Taniguchi	46
11	Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial) 2021 ·Liver Cancer ·Tadatoshi Takayama, Kiyoshi Hasegawa, Namiki Izumi, Masatoshi Kudo, Mitsuo Shimada, Naoki Yamanaka, Masafumi Inomata, Shuichi Kaneko, Hisashi Nakayama, Yoshikuni Kawaguchi, Kosuke Kashiwabara, Ryosuke Tateishi, Shuichiro Shiina, Kazuhiko Koike, Yutaka Matsuyama, Masao Omata, Masatoshi Makuuchi, Norihiro Kokudo	103
12	A cost‐effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan 2021 ·JGH Open ·(unknown), Sachie Inoue, (unknown), (unknown), (unknown), Ryosuke Tateishi	0
13	Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy 2018 ·Journal of Hepatology ·(unknown), Tatsuya Minami, Ryosuke Tateishi, (unknown), Ryo Nakagomi, Naoto Fujiwara, Masaya Sato, Koji Uchino, Kenichiro Enooku, Hayato Nakagawa, Yoshinari Asaoka, Shuichiro Shiina, Kazuhiko Koike	62
14	Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation 2014 ·JONA The Journal of Nursing Administration ·Naoto Fujiwara, Ryosuke Tateishi, Mayuko Kondo, Tatsuya Minami, Shintaro Mikami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Ryota Masuzaki, Hayato Nakagawa, Yuji Kondo, Yoshinari Asaoka, Shuichiro Shiina, Haruhiko Yoshida, Kazuhiko Koike	1
15	Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma 2008 ·The American Journal of Gastroenterology ·Jun Imamura, Ryosuke Tateishi, Shuichiro Shiina, Eriko Goto, Takahisa Sato, Takamasa Ohki, Ryota Masuzaki, Tadashi Goto, Hideo Yoshida, Fumihiko Kanai, Keisuke Hamamura, Shuntaro Obi, Haruhiko Yoshida, Masao Omata	81
16	Sampling methods for validation of large area land cover mapping 2007 ·National Remote Sensing Bulletin ·Ryosuke Tateishi, (unknown), (unknown), (unknown), (unknown)	3
17	Evaluation of liver fibrosis by Fibro Scan502 2005 ·Yosuke Sugioka, Ryosuke Tateishi, (unknown), Tomoko Okano, (unknown), (unknown), Atsushi Suzuki, (unknown), Haruhiko Yoshida, (unknown), Katsu Takenaka, Masao Omata	0
18	Answer 2004 ·Gut ·Hideo Yoshida, Ryosuke Tateishi, Yasuhiko Arakawa, Michio Sata, Shigetoshi Fujiyama, S. Nishiguchi, Hiromi Ishibashi, Yasushi Shiratori, Masao Omata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
19	Studies on the Correction of Geometric Distortion of SPOT HRV Image Data 1988 ·National Remote Sensing Bulletin ·(unknown), Ryosuke Tateishi, K. Tsuchiya	0
20	Argentaffin granules in endocrine cells in human duodenal mucosa. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Ryosuke Tateishi	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact